Myrioxazine A

Details

Top
Internal ID 619e0d68-88b5-4d4e-953b-64c2aa105895
Taxonomy Organoheterocyclic compounds > Quinolidines
IUPAC Name (5R,9S,13R)-3-oxa-1-azatricyclo[7.3.1.05,13]tridecane
SMILES (Canonical) C1CC2CCCN3C2C(C1)COC3
SMILES (Isomeric) C1C[C@H]2CCCN3[C@H]2[C@@H](C1)COC3
InChI InChI=1S/C11H19NO/c1-3-9-5-2-6-12-8-13-7-10(4-1)11(9)12/h9-11H,1-8H2/t9-,10-,11+/m0/s1
InChI Key UMXDWOAONBMYJH-GARJFASQSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C11H19NO
Molecular Weight 181.27 g/mol
Exact Mass 181.146664230 g/mol
Topological Polar Surface Area (TPSA) 12.50 Ų
XlogP 2.10
Atomic LogP (AlogP) 1.85
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
(5R,9S,13R)-3-Oxa-1-azatricyclo[7.3.1.05,13]tridecane

2D Structure

Top
2D Structure of Myrioxazine A

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9863 98.63%
Caco-2 + 0.8321 83.21%
Blood Brain Barrier + 0.9750 97.50%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Lysosomes 0.5707 57.07%
OATP2B1 inhibitior - 0.8585 85.85%
OATP1B1 inhibitior + 0.9572 95.72%
OATP1B3 inhibitior + 0.9504 95.04%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior + 0.5750 57.50%
BSEP inhibitior - 0.7982 79.82%
P-glycoprotein inhibitior - 0.9791 97.91%
P-glycoprotein substrate - 0.9339 93.39%
CYP3A4 substrate - 0.6427 64.27%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate + 0.3572 35.72%
CYP3A4 inhibition - 0.9468 94.68%
CYP2C9 inhibition - 0.8790 87.90%
CYP2C19 inhibition - 0.7365 73.65%
CYP2D6 inhibition - 0.9304 93.04%
CYP1A2 inhibition - 0.5384 53.84%
CYP2C8 inhibition - 0.9554 95.54%
CYP inhibitory promiscuity - 0.8710 87.10%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9400 94.00%
Carcinogenicity (trinary) Non-required 0.5843 58.43%
Eye corrosion - 0.7436 74.36%
Eye irritation + 0.9745 97.45%
Skin irritation + 0.5154 51.54%
Skin corrosion - 0.6208 62.08%
Ames mutagenesis - 0.5400 54.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4935 49.35%
Micronuclear - 0.6500 65.00%
Hepatotoxicity + 0.7213 72.13%
skin sensitisation - 0.8539 85.39%
Respiratory toxicity - 0.5000 50.00%
Reproductive toxicity - 0.7222 72.22%
Mitochondrial toxicity + 0.7875 78.75%
Nephrotoxicity + 0.6753 67.53%
Acute Oral Toxicity (c) III 0.6090 60.90%
Estrogen receptor binding - 0.9246 92.46%
Androgen receptor binding - 0.6674 66.74%
Thyroid receptor binding - 0.7755 77.55%
Glucocorticoid receptor binding - 0.7876 78.76%
Aromatase binding - 0.7834 78.34%
PPAR gamma - 0.8695 86.95%
Honey bee toxicity - 0.8463 84.63%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.5200 52.00%
Fish aquatic toxicity - 0.8863 88.63%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2140 P48775 Tryptophan 2,3-dioxygenase 90.87% 98.46%
CHEMBL241 Q14432 Phosphodiesterase 3A 88.19% 92.94%
CHEMBL4040 P28482 MAP kinase ERK2 87.65% 83.82%
CHEMBL253 P34972 Cannabinoid CB2 receptor 86.89% 97.25%
CHEMBL3137262 O60341 LSD1/CoREST complex 85.95% 97.09%
CHEMBL240 Q12809 HERG 84.54% 89.76%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.52% 95.89%
CHEMBL5203 P33316 dUTP pyrophosphatase 83.33% 99.18%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 81.83% 96.09%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 80.92% 95.50%
CHEMBL3105 P09874 Poly [ADP-ribose] polymerase-1 80.81% 93.90%
CHEMBL1795139 Q8IU80 Transmembrane protease serine 6 80.42% 98.33%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 11263869
LOTUS LTS0074958
wikiData Q105275804